Psoriasis

LATEST NEWS

Steroid-Free Vtama Cream Approved for Plaque Psoriasis

By

Diana Ernst, RPh

The approval was based on data from 2 identical phase 3 studies, PSOARING 1 and PSOARING 2.

FDA Decision on Bimekizumab for Plaque Psoriasis Delayed

By

Brian Park, PharmD

Bimekizumab is an investigational humanized monoclonal IgG1 antibody that selectively inhibits both interleukin (IL)-17A and IL-17F.

High Erythrocyte Mean Corpuscular Volume Predicts Methotrexate Response in PsA

By

Sheila Jacobs

Researchers investigated the generalizability of a previous study finding that increased mean corpuscular volume complements clinical response in psoriatic arthritis.

Candidate Biomarkers Identified for Psoriasis Progression

Candidate biomarkers for disease progression in psoriasis have been identified, according to a review published online.

Brodalumab Promising for Plaque Psoriasis 

By

Aryanna Garber, MS

Treatment with brodalumab was well tolerated and produced high levels of skin clearance over 120 weeks in patients with moderate to severe plaque psoriasis, according to results of a post hoc analysis of phase 2 and 3 clinical trials of brodalumab published in the Journal of the European Academy of Dermatology and Venereology. To address…

Risk for Ectopic Pregnancy Increased for Women With Psoriasis

Women with psoriasis have a significantly increased risk for ectopic pregnancy (EP), which is highest for those with moderate-to-severe psoriasis.

Short Version of Patient Benefit Index May Be Valid Tool for Psoriasis

By

Colby Stong

Clinicians develop and test a 10-item short version of the Patient Benefit Index Standard version (PBI-S) for use by patients with psoriasis.

Efficacy Response Maintained With Deucravacitinib in Plaque Psoriasis Trial

By

Brian Park, PharmD

The POETYK PSO-LTE trial evaluated deucravacitinib 6mg orally once daily in 1221 adults with moderate to severe plaque psoriasis.

Comparing the Efficacy, Safety of Systemic Therapies in the Treatment of PsA Manifestations

By

Rheumatology Advisor Contributing Writer

Authors of a systematic review compared the efficacy and safety of systemic therapies in the treatment of manifestations of active psoriatic arthritis.

Treatment Refractory and Super-Responders in Psoriasis Biologic Agent Treatment

By

Ron Goldberg

Researchers sought to recognize and describe the patients with psoriasis at both ends of the biologic agent treatment spectrum.